ijms-logo

Journal Browser

Journal Browser

Recent Advances in Molecular Imaging and Therapy

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 31 January 2026 | Viewed by 7

Special Issue Editor

Department of Radiology, Diagnostic and Research PET/MR Center, Nemours Children’s Health, Wilmington, DE 19803, USA
Interests: molecular Imaging; radiotheranostics' neuroimaging; nuclear medicine; clinical translation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Since the Food and Drug Administration (FDA) approved lutetium Lu 177 dotatate for the treatment of pediatric patients 12 years and older with somatostatin receptor (SSTR)-positive gastroenteropancreatic neuroendocrine tumors in 2024, and further approved Gozellix (Ga-68 gozetotide injection) as a radioactive diagnostic agent for prostate cancer imaging in 2025, over 60 radiopharmaceuticals have been certified for the diagnosis or treatment of cancers, neurodegenerative disorders, and cardiovascular diseases.

Molecular imaging and its accompanying therapy are playing an increasingly important roles in the development of predictive, preventive, personalized, and participatory medicine. However, many challenges, including target selection, subject polymorphism, imaging specificity, early diagnosis, technical hurdles, prognosis, and long-term toxicity, still limit the wide clinical translation of molecular imaging agents and therapeutics.

We are pleased to invite you to contribute to this Special Issue, which focuses on recent advances in molecular imaging and therapy. Your original research and review papers have the potential to significantly advance our understanding and application of various imaging modalities and therapeutic strategies. We welcome all contributions, including basic, translational, and clinical research. Suitable subjects range from target selection and lead drug identification to in vitro evaluation, in vivo validation, bench-to-bedside transition, and clinical investigation. Molecular imaging and therapeutic research that correlates imaging findings or treatment outcomes with molecular-level biomarkers will fit the scope of the International Journal of Molecular Sciences particularly.

I look forward to receiving your contributions.

Dr. Xuyi Yue
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • molecular imaging
  • therapy
  • clinical translation
  • precision medicine
  • radiotheranostics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop